Loading...
INDEX: NASDAQ
SYMBOL: ACAD
NAME: ACADIA Pharmaceuticals Inc.
UPVOTES: 94
DOWNVOTES: 89


Description

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system disorders. The Company's lead drug candidate, NUPLAZID (pimavanserin), is under development for the treatment of Parkinson's disease psychosis (PDP). NUPLAZID is a selective serotonin inverse agonist (SSIA), targeting 5-HT2A receptors. The Company's Pimavanserin is a chemical entity, which has completed Phase III development, and is indicated for the treatment of Parkinson's disease psychosis. NUPLAZID (pimavanserin) is a selective serotonin inverse agonist preferentially targeting the 5-HT2A receptor, a key serotonin receptor that plays a role in psychosis. Through this mechanism, NUPLAZID has demonstrated efficacy in Parkinson's disease psychosis in its Phase III pivotal trial and avoids the side effects of existing antipsychotics.

Read Full Descript at Reuters

ACAD Message Board



Todays Most
Up-Voted
Todays Most
Down-Voted
Most
Recent Voted
All Time Most
Up-Voted
All Time Most
Down-Voted
Top
Voted Index

NASDAQ



Stock SymbolUp VotesDown VotesVote
AMDA10
AREX10
LLNW10
ARRY10
A10
NUAN10
SEDG10
AND10
F10
AMRS10
Stock SymbolUp VotesDown VotesVote
TSLA337124
CBIS326146
AMD311241
DIS181112
AMZN173117
NVDA158103
KTOS14495
NFLX14098
NAT11676
MSRT143106
Stock SymbolUp VotesDown VotesVote
COF51
XRX51
NYSE:LMT73
NUAN30
AMFL41
AC42
AUMN31
UNXL31
LLNW31
KNSC31
Stock SymbolUp VotesDown VotesVote
COF179
PULM147
82
ABBV115
AUMN105
MIK94
MNGA83
DFS127
ASTI105
ENDRQ61
Stock SymbolUp VotesDown VotesVote
TSLA337124
CBIS326146
AMD311241
DIS181112
AMZN173117
NVDA158103
KTOS14495
NFLX14098
NAT11676
MSRT143106

Last 10 Stocks Voted On

Stock SymbolActionVote
APAFFDOWNVOTE
VKTXDOWNVOTE
DRYSDOWNVOTE
SEDGUPVOTE
AMDAUPVOTE
AGRXDOWNVOTE
ACOLDOWNVOTE
ANDUPVOTE
AREXUPVOTE
AIDOWNVOTE